Shashank Rohatagi

Pharmacokinetics of Triamcinolone Acetonide After Intravenous, Oral, and Inhaled Administration

Hartmut Derendorf, Günther Hochhaus, Shashank Rohatagi et al. · The Journal of Clinical Pharmacology · 1995 · 112 citations

Population Pharmacokinetics and Pharmacodynamics of Ciclesonide

Shashank Rohatagi, Vikram Arya, Karl Zech et al. · The Journal of Clinical Pharmacology · 2003 · 105 citations

Ciclesonide, a Novel Inhaled Steroid, Does Not Affect Hypothalamic-Pituitary-Adrenal Axis Function in Patients With Moderate-to-Severe Persistent Asthma

Stanley J. Szefler, Shashank Rohatagi, J. E. Williams et al. · CHEST Journal · 2005 · 91 citations

Asthma, Adrenal Gland, Novel Inhaled Steroid +7

Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON‐TIMI 38

Rebecca E. Wrishko, C. Steven Ernest, David S. Small et al. · The Journal of Clinical Pharmacology · 2009 · 83 citations

Pras-am Exposures, Pharmacotherapy, Physiologically-based Pharmacokinetic Modeling +23

Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide.

Shashank Rohatagi, Yongyi Luo, Liduo Shen et al. · PubMed · 2005 · 81 citations

Asthma, Lung Inflammation, Glucocorticoid +21